These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

790 related items for PubMed ID: 19736471

  • 1. Modifying cyclosporine associated renal allograft dysfunction.
    Mohapatra N, Vanikar AV, Patel RD, Trivedi HL.
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
    [Abstract] [Full Text] [Related]

  • 2. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 4. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 5. Study of acute antibody-mediated rejection in renal allograft biopsies.
    Kanodia KV, Vanikar AV, Trivedi HL.
    Transplant Proc; 2008 May 15; 40(4):1099-103. PubMed ID: 18555123
    [Abstract] [Full Text] [Related]

  • 6. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G.
    Transpl Int; 2016 Jan 15; 29(1):23-33. PubMed ID: 26729582
    [Abstract] [Full Text] [Related]

  • 7. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
    Knight RJ, Podder H, Kerman RH, Lawless A, Katz SM, Van Buren CT, Gaber AO, Kahan BD.
    Transplantation; 2010 Mar 27; 89(6):727-32. PubMed ID: 20195219
    [Abstract] [Full Text] [Related]

  • 8. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado JM, Moreso F, Fernandez A, Torras J, Riera L, Castelao AM, Alsina J.
    Nephrol Dial Transplant; 1998 Oct 27; 13(10):2601-4. PubMed ID: 9794567
    [Abstract] [Full Text] [Related]

  • 9. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov 27; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan 27; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 11. Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, El-Baz M, Shokeir AA, Ghoneim MA.
    Ann Transplant; 2008 Jan 27; 13(4):46-54. PubMed ID: 19034223
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
    Song Y, Xue W, Tian P, Ding X, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X, Qin G, Fan X.
    Eur J Clin Pharmacol; 2011 Jun 27; 67(6):553-62. PubMed ID: 21279337
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A, Druskis V, Laurinavicius A.
    Clin Nephrol; 2001 Dec 27; 56(6):S27-9. PubMed ID: 11770808
    [Abstract] [Full Text] [Related]

  • 14. Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.
    Ołdakowska-Jedynak U, Paczek L, Mucha K, Foroncewicz B, Perkowska-Ptasińska A.
    Transplant Proc; 2006 Dec 27; 38(1):66-8. PubMed ID: 16504666
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
    Ruggenenti P, Cravedi P, Gotti E, Plati A, Marasà M, Sandrini S, Bossini N, Citterio F, Minetti E, Montanaro D, Sabadini E, Tardanico R, Martinetti D, Gaspari F, Villa A, Perna A, Peraro F, Remuzzi G.
    PLoS Med; 2021 Jun 27; 18(6):e1003668. PubMed ID: 34166370
    [Abstract] [Full Text] [Related]

  • 16. Impact of immunosuppression on the incidence of early subclinical renal allograft rejection: implications for protocol biopsy policy.
    Roberts IS, Stratopoulos C, Zilvetti M, Reddy S, Friend PJ.
    Transpl Int; 2009 Aug 27; 22(8):831-6. PubMed ID: 19386079
    [Abstract] [Full Text] [Related]

  • 17. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B, Höcker B.
    Pediatr Transplant; 2006 Sep 27; 10(6):721-9. PubMed ID: 16911497
    [Abstract] [Full Text] [Related]

  • 18. The role of the protocol biopsies in renal allograft recipients.
    Baczkowska T, Perkowska-Francka A, Durlik M, Cieciura T, Nowacka-Cieciura E, Pazik J, Lewandowska D, Mroz A, Matlosz B, Chmura A, Galazka Z, Lao M.
    Transplant Proc; 2003 Sep 27; 35(6):2179-81. PubMed ID: 14529881
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D, Motte G, Billerey C, Bresson-Vautrin C, Vautrin P, Rebibou JM, Saint-Hillier Y, Chalopin JM.
    Transpl Int; 2002 Sep 27; 15(8):387-92. PubMed ID: 12221456
    [Abstract] [Full Text] [Related]

  • 20. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec 27; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.